# Marblegate Capital Corp: filings

MGTE · OTC · CIK 1965052 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mgte.md) · [Financials](/companies/mgte/financials.md) · [Filings](/companies/mgte/filings.md) · [Insiders](/companies/mgte/insiders.md)

## Reports and events: 18 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (UPLOAD 12, DRSLTR 10, 3 7, 4 7, 8-K 7, DRS/A 6, 10-Q 5, CORRESP 4, 10-K 2, 424B3 2, 425 2, 8-K/A 2, DEFA14A 2, S-4/A 2, SEC STAFF LETTER 2, 8-A12G 1, DEF 14A 1, DRS 1, EFFECT 1, NT 10-K 1, S-4 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-13 | 17:29 ET | [10-Q](/filings/0001193125-26-349672.md) | Quarterly report, period 2026-06-30 | 0001193125-26-349672 |
| 2026-06-12 | 17:29 ET | [8-K/A](/filings/0001193125-26-269744.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-269744 |
| 2026-06-12 | 16:15 ET | [8-K](/filings/0001193125-26-269464.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-269464 |
| 2026-05-14 | 16:30 ET | [10-Q](/filings/0001193125-26-224163.md) | Quarterly report, period 2026-03-31 | 0001193125-26-224163 |
| 2026-04-29 | 08:00 ET | [DEF 14A](/filings/0001193125-26-189076.md) | Proxy statement, period 2026-06-11 | 0001193125-26-189076 |
| 2026-03-26 | 08:30 ET | [10-K](/filings/0001193125-26-125186.md) | Annual report, period 2025-12-31 | 0001193125-26-125186 |
| 2026-01-06 | 21:55 ET | [8-K](/filings/0001193125-26-003211.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-003211 |
| 2025-11-13 | 18:53 ET | [10-Q](/filings/0001193125-25-278207.md) | Quarterly report, period 2025-09-30 | 0001193125-25-278207 |
| 2025-08-14 | 17:27 ET | [10-Q](/filings/0000950170-25-109084.md) | Quarterly report, period 2025-06-30 | 0000950170-25-109084 |
| 2025-07-22 | 17:25 ET | [8-K](/filings/0000950170-25-097631.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0000950170-25-097631 |
| 2025-07-01 | 08:10 ET | [8-K](/filings/0000950170-25-091890.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-091890 |
| 2025-05-15 | 16:51 ET | [8-K/A](/filings/0000950170-25-072799.md) | 9.01 Financial statements and exhibits | 0000950170-25-072799 |
| 2025-05-15 | 16:01 ET | [10-Q](/filings/0000950170-25-072547.md) | Quarterly report, period 2025-03-31 | 0000950170-25-072547 |
| 2025-04-23 | 16:15 ET | [8-K](/filings/0000950170-25-057388.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-057388 |
| 2025-04-17 | 18:49 ET | [SCHEDULE 13D](/filings/0000950170-25-055668.md) | Ownership report, active investor | 0000950170-25-055668 |
| 2025-04-11 | 16:30 ET | [8-K](/filings/0001193125-25-079142.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.01 Delisting notice; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.06 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-079142 |
| 2025-04-10 | 07:00 ET | [8-K](/filings/0001193125-25-077329.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-077329 |
| 2025-04-07 | 16:31 ET | [10-K](/filings/0001193125-25-074703.md) | Annual report, period 2024-12-31 | 0001193125-25-074703 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.